Ruixin micro: the subsidiary waives the preemptive right of Shanghai Hejian to increase its capital in the same proportion

China’s E-bike Brands Going Global: A Review of 26 Leading Players

With the global e-bike market continuing to expand, Chinese e-bike companies are gradually shifting from being a manufacturing powerhouse to becoming a meaningful force in global competition. This article reviews a group of Chinese e-bike players and examines their overseas positioning and market entry paths—looking at how Chinese brands are securing a foothold in the next wave of globalization.

Kanghong’s Conbercept Receives Marketing Authorization in Guyana

Kanghong Pharmaceutical (康弘药业) said its subsidiary Kanghong Bioscience had received a drug registration certificate from Guyana’s Food and Drug Department for conbercept ophthalmic injection, marketed under the brand name Lumitin (朗沐).

ByteDance’s Proposed US$20 Billion Offshore Loan Draws More Than US$30 Billion of Demand

ByteDance (字节跳动) has drawn more than US$30 billion of demand for a proposed syndicated loan that could become its largest offshore borrowing, Bloomberg reported on Aug. 19, underscoring lenders’ appetite to finance the TikTok owner’s expanding artificial-intelligence infrastructure plans.

CRSC Wins Eight Significant Bids with Total Value of CNY 2.17 Bn

CRSC wins two bids on the railway system market and six bids on the urban railway market in recent two months, which is likely to help the company achieve growth again in Q4 2020 and fiscal year 2021.

Does Dual-listed CRSC Create a Room for Arbitrage Deals?

One of the largest China's rail transit related systems manufacturers is now listed both on HKEX and the Star Market. Let's track the two stocks' performance.